Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 68071-3419

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68071-3419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3419 6)

Label for esomeprazole magnesium 20 mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The package contains 60 capsules. The label includes dosage form, strength, lot and serial numbers, storage instructions, and manufacturer information including Graviti Pharmaceuticals Pvt. Ltd. India. It states the capsules contain 22.25 mg esomeprazole magnesium trihydrate equivalent to 20 mg esomeprazole.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 01)

Chemical structure of esomeprazole magnesium showing molecular components, including aromatic rings, functional groups, and magnesium ion coordinated with three water molecules (Mg2+ · 3 H2O).*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (B201c94c 128a 4ae1 86a1 057c4c895839 02)

A line graph depicting the percentage maintained over a six-month period for esomeprazole magnesium delayed-release capsules 40 mg compared to placebo. The graph includes four lines representing different sample sizes and treatment groups, showing a trend of higher maintenance percentages for the drug groups compared to placebo.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (B201c94c 128a 4ae1 86a1 057c4c895839 03)

A line graph depicting the percent maintained over six months for esomeprazole magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses, compared to a placebo. The y-axis shows percent maintained from 0 to 100, and the x-axis shows time in months from 1 to 6. The 40 mg dose maintains the highest percentage, followed by 20 mg, 10 mg, and placebo groups.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) Figure (B201c94c 128a 4ae1 86a1 057c4c895839 04)

A line graph showing the percent of patients symptom-free over 28 diary days, comparing esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses to a placebo. The y-axis represents the percentage of symptom-free patients, and the x-axis shows the diary days from 0 to 28.*

FDA Label Image

Image (B201c94c 128a 4ae1 86a1 057c4c895839 05)

A line chart depicting the percent of patients symptom-free over 28 diary days for esomeprazole magnesium delayed-release capsules at 40 mg and 20 mg doses, compared to placebo. The y-axis shows the percent symptom-free, while the x-axis shows the diary days. Three lines represent the different groups: 40 mg, 20 mg, and placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.